220 related articles for article (PubMed ID: 11153678)
1. Evolution of HIV-1 multidrug-resistant genotypes during combination therapy and after the cessation of antiretroviral drugs.
Yahi N; Tourrès C; Tivoli N; Colson P; Dhiver C; Quinson AM; Tamalet C
AIDS; 2000 Dec; 14(18):2943-5. PubMed ID: 11153678
[No Abstract] [Full Text] [Related]
2. Phenotypic resistance pattern of HIV-1 isolates with zidovudine and/or multidrug resistance mutations after didanosine-stavudine combination therapy.
Pellegrin I; Segondy M; Garrigue I; Izopet J; Montes B; Pellegrin JL; Reynes J; Massip P; Puel J; Fleury H
J Acquir Immune Defic Syndr; 2000 Dec; 25(5):465-6. PubMed ID: 11141248
[No Abstract] [Full Text] [Related]
3. Reverse transcriptase fidelity and HIV-1 variation.
Balzarini J; Pelemans H; De Clercq E; Karlsson A; Kleim JP
Science; 1997 Jan; 275(5297):229-30; author reply 230-1. PubMed ID: 8999551
[No Abstract] [Full Text] [Related]
4. Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations.
Monno L; Appice A; Cavaliere R; Scarabaggio T; Angarano G
J Infect Dis; 1999 Aug; 180(2):568-71. PubMed ID: 10395885
[No Abstract] [Full Text] [Related]
5. Identification of reverse transcriptase mutations associated with HIV-1 drug resistance mainly against non-nucleoside reverse transcriptase inhibitors in treatment-naive patients.
Magiorkinis E; Paraskevis D; Lazanas M; Kiosses VG; Gargalianos P; Hatzakis A
AIDS; 1999 Jul; 13(10):1276-8. PubMed ID: 10416535
[No Abstract] [Full Text] [Related]
6. Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir.
Van Laethem K; Witvrouw M; Balzarini J; Schmit JC; Sprecher S; Hermans P; Leal M; Harrer T; Ruiz L; Clotet B; Van Ranst M; Desmyter J; De Clercq E; Vandamme AM
AIDS; 2000 Mar; 14(4):469-71. PubMed ID: 10770556
[No Abstract] [Full Text] [Related]
7. Infection by zidovudine-resistant HIV-1 compromises the virological response to stavudine in a drug-naive patient.
de Ronde A; van Dooren M; de Rooij E; van Gemen B; Lange J; Goudsmit J
AIDS; 2000 Nov; 14(16):2632-3. PubMed ID: 11101087
[No Abstract] [Full Text] [Related]
8. Current insights into reverse transcriptase inhibitor-associated resistance.
Wainberg MA; White AJ
Antivir Ther; 2001; 6 Suppl 2():11-9. PubMed ID: 11678474
[No Abstract] [Full Text] [Related]
9. Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.
Gómez-Cano M; Rubio A; Puig T; Pérez-Olmeda M; Ruiz L; Soriano V; Pineda JA; Zamora L; Xaus N; Clotet B; Leal M
AIDS; 1998 Jun; 12(9):1015-20. PubMed ID: 9662197
[TBL] [Abstract][Full Text] [Related]
10. Selection by AZT and rapid replacement in the absence of drugs of HIV type 1 resistant to multiple nucleoside analogs.
Lukashov VV; Huismans R; Jebbink MF; Danner SA; de Boer RJ; Goudsmit J
AIDS Res Hum Retroviruses; 2001 Jun; 17(9):807-18. PubMed ID: 11429122
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral Resistance Mutations (revised April 2001).
;
HIV Clin Trials; 2001; 2(4):346-55. PubMed ID: 11590539
[No Abstract] [Full Text] [Related]
12. Multi-drug resistant HIV-1.
Omrani AS; Pillay D
J Infect; 2000 Jul; 41(1):5-11. PubMed ID: 10942635
[No Abstract] [Full Text] [Related]
13. [Evolution of HIV resistance mutations in the Valme referral center].
Nogales MC; Castro C; Martín-Mazuelos E
Enferm Infecc Microbiol Clin; 2007 Feb; 25(2):159. PubMed ID: 17288915
[No Abstract] [Full Text] [Related]
14. HIV-1 drug resistance in newly infected individuals.
Boden D; Hurley A; Zhang L; Cao Y; Guo Y; Jones E; Tsay J; Ip J; Farthing C; Limoli K; Parkin N; Markowitz M
JAMA; 1999 Sep 22-29; 282(12):1135-41. PubMed ID: 10501116
[TBL] [Abstract][Full Text] [Related]
15. Detection of multiple drug-resistance-associated pol mutations in cervicovaginal secretions from women largely treated with antiretroviral agents.
Di Stefano M; Fiore JR; Monno L; Lepera A; Pastore G; Angarano G
AIDS; 1999 May; 13(8):992-4. PubMed ID: 10371183
[No Abstract] [Full Text] [Related]
16. Case report of a novel amino acid deletion in codon 67 and T69G substitution in the reverse transcriptase of HIV-1.
Giri J; Rueda HJ; Monticelli A; Planes N
Antivir Ther; 2000 Sep; 5(3):227-8. PubMed ID: 11075943
[No Abstract] [Full Text] [Related]
17. Reverse transcriptase fidelity and HIV-1 variation.
Keulen W; Nijhuis M; Schuurman R; Berkhout B; Boucher C
Science; 1997 Jan; 275(5297):229; author reply 230-1. PubMed ID: 8999550
[No Abstract] [Full Text] [Related]
18. Detection of drug resistance associated mutations in HIV primary infection within the UK.
Pillay D; Cane PA; Shirley J; Porter K
AIDS; 2000 May; 14(7):906-8. PubMed ID: 10839606
[No Abstract] [Full Text] [Related]
19. High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Côte d'Ivoire.
Adjé C; Cheingsong R; Roels TH; Maurice C; Djomand G; Verbiest W; Hertogs K; Larder B; Monga B; Peeters M; Eholie S; Bissagene E; Coulibaly M; Respess R; Wiktor SZ; Chorba T; Nkengasong JN;
J Acquir Immune Defic Syndr; 2001 Apr; 26(5):501-6. PubMed ID: 11391173
[TBL] [Abstract][Full Text] [Related]
20. Changes in the rate of genotypic resistance to antiretroviral drugs in Spain.
Gallego O; Ruiz L; Vallejo A; Ferrer E; Rubio A; Clotet B; Leal M; Soriano V;
AIDS; 2001 Sep; 15(14):1894-6. PubMed ID: 11579258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]